FierceBiotech (@fiercebiotech) 's Twitter Profile
FierceBiotech

@fiercebiotech

The dominant B2B news brand for biotech. Delivering news, revealing insights straight to your inbox.

ID: 18294197

linkhttp://FierceBiotech.com calendar_today21-12-2008 22:21:58

29,29K Tweet

101,101K Takipçi

636 Takip Edilen

FierceBiotech (@fiercebiotech) 's Twitter Profile Photo

Pfizer and Arvinas have axed two phase 3 trials from their estrogen receptor degrader R&D plan in the wake of mixed data. Arvinas is also is laying off a third of its staff to cut costs and extend its cash runway. $PFE $ARVN fiercebiotech.com/biotech/arvina…